232 related articles for article (PubMed ID: 18606869)
1. Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability.
Fainaru O; Adini I; Benny O; Bazinet L; Pravda E; D'Amato R; Folkman J
FASEB J; 2008 Oct; 22(10):3728-35. PubMed ID: 18606869
[TBL] [Abstract][Full Text] [Related]
2. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
[TBL] [Abstract][Full Text] [Related]
3. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
4. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo.
Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J
J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236
[TBL] [Abstract][Full Text] [Related]
5. p18, a novel adaptor protein, regulates pulmonary endothelial barrier function via enhanced endocytic recycling of VE-cadherin.
Chichger H; Duong H; Braza J; Harrington EO
FASEB J; 2015 Mar; 29(3):868-81. PubMed ID: 25404710
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium.
Shen W; Li S; Chung SH; Zhu L; Stayt J; Su T; Couraud PO; Romero IA; Weksler B; Gillies MC
Eur J Cell Biol; 2011 Apr; 90(4):323-32. PubMed ID: 21168935
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
Wood JM
Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial-cadherin and vascular stability.
Dejana E; Giampietro C
Curr Opin Hematol; 2012 May; 19(3):218-23. PubMed ID: 22395663
[TBL] [Abstract][Full Text] [Related]
9. IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis.
Yamaoka-Tojo M; Tojo T; Kim HW; Hilenski L; Patrushev NA; Zhang L; Fukai T; Ushio-Fukai M
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):1991-7. PubMed ID: 16763158
[TBL] [Abstract][Full Text] [Related]
10. Cell-cell junctions and vascular endothelial growth factor in rat lung as affected by ischemia/reperfusion and preconditioning with inhaled nitric oxide.
Waldow T; Witt W; Janke A; Ulmer A; Buzin A; Matschke K
J Surg Res; 2009 Nov; 157(1):30-42. PubMed ID: 19500802
[TBL] [Abstract][Full Text] [Related]
11. VE-cadherin increases the half-life of VEGF receptor 2.
Calera MR; Venkatakrishnan A; Kazlauskas A
Exp Cell Res; 2004 Oct; 300(1):248-56. PubMed ID: 15383331
[TBL] [Abstract][Full Text] [Related]
12. S-nitrosylation of beta-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability.
Thibeault S; Rautureau Y; Oubaha M; Faubert D; Wilkes BC; Delisle C; Gratton JP
Mol Cell; 2010 Aug; 39(3):468-76. PubMed ID: 20705246
[TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP and acidic fibroblast growth factor have opposing effects on tight and adherens junctions in microvascular endothelial cells in vitro.
Dye JF; Leach L; Clark P; Firth JA
Microvasc Res; 2001 Sep; 62(2):94-113. PubMed ID: 11516239
[TBL] [Abstract][Full Text] [Related]
14. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
15. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell Piezo1 mediates pressure-induced lung vascular hyperpermeability via disruption of adherens junctions.
Friedrich EE; Hong Z; Xiong S; Zhong M; Di A; Rehman J; Komarova YA; Malik AB
Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12980-12985. PubMed ID: 31186359
[TBL] [Abstract][Full Text] [Related]
17. Negative regulation of VEGF-induced vascular leakage by blockade of angiotensin II type 1 receptor.
Sano H; Hosokawa K; Kidoya H; Takakura N
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2673-80. PubMed ID: 16973968
[TBL] [Abstract][Full Text] [Related]
18. The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expression.
Hofmann S; Grasberger H; Jung P; Bidlingmaier M; Vlotides J; Janssen OE; Landgraf R
Eur J Med Res; 2002 Apr; 7(4):171-6. PubMed ID: 12010652
[TBL] [Abstract][Full Text] [Related]
19. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
[TBL] [Abstract][Full Text] [Related]
20. Doxycycline attenuates burn-induced microvascular hyperpermeability.
Stagg HW; Whaley JG; Tharakan B; Hunter FA; Jupiter D; Little DC; Davis ML; Smythe WR; Childs EW
J Trauma Acute Care Surg; 2013 Dec; 75(6):1040-6; discussion 1046. PubMed ID: 24256679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
